Figure 2.
Kaplan-Meier survival curves for female (A) and male (B) patients with (1) rheumatoid arthritis (RA, N=33 641 females, N=9094 males), (2) ankylosing spondylitis (AS, N=4163 females, N=5544 males), (3) psoriatic arthritis (PSA, N=7565 females, N=6214 males), (4) systemic lupus erythematosus (SLE, N=9315 females, N=1125 males), (5)systemic sclerosis (SSC, N=1,998 females, N=279 males) and for age-matched and gender-matched individuals from the general population (1:5 exposed:unexposed ratio) included in our cohort between 1 January 2015 and 31 December 2019. Analysis time in months.